Innovative SME

An EATRIS institution will work with a biotechnology company focused on kinase inhibitors. This project will focus on a kinase phosphorylating tau protein, which has been shown to be involved in neurological disorders like Alzheimer’s disease (AD). The EATRIS institution will provide in vitro models for profiling novel compounds in a cell-based Tau aggregation assay.

Website by Lewis+Humphreys